Presse / Média
- 13 résultats
Rechercher les résultats
-
ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres for treatment of liver tumors'
4/19/22
1 élément de Couverture média
Presse/Média: Research
-
ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres for treatment of liver tumors'
4/19/22
67 éléments de Couverture média
Presse/Média: Research
-
ABK Biomedical Announces First Patient Treated in First-in-Human Clinical Study with Eye90 microspheres™ for treatment of liver tumors
5/18/22
1 élément de Couverture média
Presse/Média: Research
-
-
New Clinical Study for treatment of liver tumors
4/20/22
1 élément de Couverture média
Presse/Média: Research
-
Novel radiopaque microspheres in Y-90 radioembolization show potential to map absorbed...
2/7/20
1 élément de Couverture média
Presse/Média: Research
-
Stone formation: PGIMER experts debunk myths
5/13/23
1 élément de Couverture média
Presse/Média: Research
-
U.S. Patents Awarded to Inventors in North Carolina (Nov. 23)
11/23/22
1 élément de Couverture média
Presse/Média: Research
-
US Patent Issued to ABK Biomedical on Aug. 10 for "Radioembolic particles" (Canadian, Chinese Inventors)
8/10/21
1 élément de Couverture média
Presse/Média: Research
-
US Patent Issued to ABK Biomedical on Nov. 22 for "Delivery device" (Canadian, American Inventors)
11/23/22
1 élément de Couverture média
Presse/Média: Research
-
Vividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
2/11/20
11 éléments de Couverture média
Presse/Média: Research
-
Vividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer
2/11/20
1 élément de Couverture média
Presse/Média: Research
-
Vividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D ...
2/12/20
1 élément de Couverture média
Presse/Média: Research